REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Immunoglobulin, Antiserum, Antibody, Or Antibody Fragment, Except Conjugate Or Complex Of The Same With Nonimmunoglobulin Material > Monoclonal Antibody Or Fragment Thereof (i.e., Produced By Any Cloning Technology) > Binds Parasitic Organism (i.e., Parasitic Protozoan, Multicellular Ectoparasite (e.g., Flea, Tick, Mite, Etc.), Or Multicellular Endoparasite (e.g., Parasitic Worm, Etc.)) Or Component Thereof Or Substance Produced By Said Parasitic Organism Binds Parasitic Organism (i.e., Parasitic Protozoan, Multicellular Ectoparasite (e.g., Flea, Tick, Mite, Etc.), Or Multicellular Endoparasite (e.g., Parasitic Worm, Etc.)) Or Component Thereof Or Substance Produced By Said Parasitic OrganismBinds Parasitic Organism (i.e., Parasitic Protozoan, Multicellular Ectoparasite (e.g., Flea, Tick, Mite, Etc.), Or Multicellular Endoparasite (e.g., Parasitic Worm, Etc.)) Or Component Thereof Or Substance Produced By Said Parasitic Organism patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.08/02/07 - 20070178100 - Trypanosoma cruzi proteome compositions and methods Molecular targets are identified in T. cruzi suitable for use in diagnosis of Chagas disease, drug development, and vaccines, including live vaccines. ... 05/24/07 - 20070116706 - Antibodies to the propeptide of candida albicans and methods of use Antibodies and agents which can bind to the propeptide of the Int1p protein of yeast microorganisms such as Candida albicans are provided which can be useful in methods for treating or preventing infections arising from such microorganisms. Microorganisms expressing the Int1p protein, such as C. albicans and S. cerevisiae, can ... 12/21/06 - 20060286109 - Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen Combination compositions including C. parvum antigen(s) or epitope(s) of interest with at least one other antigen or epitope of interest from a pathogen that causes enteric infection and/or symptoms and/or recombinant(s) and/or vector(s) and/or plasmid(s) expressing such antigen(s) or epitope(s) of interest and administration of such compositions such as to ... 09/28/06 - 20060216298 - Plasmodium falciparum antigens inducing protective antibodies The invention provides novel preparations for a broad-spectrum antiplasmodial vaccine. ... 06/29/06 - 20060140955 - Specific isotype antibodies of secretion-excretion anti-antigens of leishmania sp of promastigote or amastigote forms used as protection, resistance and curing markers of mammals to leishmaniases and to intracellular pathogenic micro-organism infections, The invention concerns immunoglobulins characterized in that they include immunoglobulins of IgG2 classes and corresponding sub-classes, specific of secretion-excretion antigens of the prosmatigote and asmatigote forms of Leishmania sp, capable of lyzing Leishmania sp amastigotes and promastigotes in vitro, and neutralizing their proliferation. ... 12/29/05 - 20050287146 - Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions A method for treating or preventing infections from yeast of the Candida species is provided wherein an immunoglobulin composition containing high titers of antibodies to staphylococcal adhesins ClfA and SdrG is administered in an amount effective to inhibit the growth and progression of Candidial infections. The compositions and methods of ... 12/22/05 - 20050281827 - Trypanosome derived apoptotic factors (taf) An antibody was raised against a synthetic 27 per peptide (ProEP2-1) blocked T. brucei and ProEP2-1-induced apoptosis in human brain vascular endothelial cells (HBVEC). The use of this and similar blocking antibodies have use both as diagnostic agents and in treatment to prevent damage arising from infection. ... 08/18/05 - 20050180978 - Novel monoclonal antibody and nematode larval antigens The present invention relates to an isolated monoclonal antibody mAb PAB-1, deposited at ATCC on 24 Jan. 2002 and accorded accession PTA-4005, which binds to a surface antigen on nematode L3. It also relates to the antigen which binds to the monoclonal antibody and uses for the monoclonal antibody and ... 08/04/05 - 20050169928 - Antibodies which bind to proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes The present invention provides antibodies that specifically bind RSP-2 proteins which are involved in the cytoadhesion of P. falciparum during ring-stage infection of erythrocytes as well as methods of using these antibodies. ... ### FreshPatents.com Support |